Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jul;39(7):2637-9.
doi: 10.1128/JCM.39.7.2637-2639.2001.

Practical strategies for detecting and confirming vancomycin-intermediate Staphylococcus aureus: a tertiary-care hospital laboratory's experience

Affiliations

Practical strategies for detecting and confirming vancomycin-intermediate Staphylococcus aureus: a tertiary-care hospital laboratory's experience

E M Marlowe et al. J Clin Microbiol. 2001 Jul.

Abstract

The clinical microbiology laboratory plays a critical role in the detection of Staphylococcus aureus with decreased susceptibility to vancomycin. Staff education and rapid laboratory response are of utmost importance. We report on our laboratory's experience and provide recommendations for the identification and confirmation of vancomycin-intermediate S. aureus.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Photo of S. aureus morphotypes from biliary culture. Isolates of S. aureus isolate 1 (MRSA) appear as classical large colonies that are yellow-white and domed with a zone of beta-hemolysis. The smaller colonies were identified as VISA. S. aureus isolate 2a (VISA) appears as a small yellow-white colony with a narrow zone of beta-hemolysis. S. aureus isolate 2b (VISA) appears as a pinpoint grey-white colony with a barely detectable zone of beta-hemolysis. Both isolate 2a and isolate 2b were domed and distinct.
FIG. 2
FIG. 2
Algorithm for detection and confirmation of VISA. This algorithm is a general guideline for workup of VISA isolates in the clinical laboratory. Algorithms should be designed for the specific hospital and patient population. Abbreviations: BHI, brain heart infusion; Vanco, vancomycin.

References

    1. Centers for Disease Control and Prevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997. Morb Mortal Wkly Rep. 1997;46:813–815. - PubMed
    1. Fridkin S K. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis. 2001;32:108–115. - PubMed
    1. Hageman, J. C., D. Peques, C. Jepson, R. Bell, M. Guinan, K. Ward, M. Cohen, J. Hindler, F. C. Tenover, S. McAllister, M. Kellum, and S. Fridkin. Case report of vancomycin-intermediate Staphylococcus aureus in a home healthcare patient. Emerg. Infect. Dis., in press. - PMC - PubMed
    1. Hiramatsu K, Artiaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet. 1997;350:1670–1673. - PubMed
    1. Kim M, Pai C H, Woo J H, Ryu J S, Hiramatsu K. Vancomycin-intermediate Staphyloccus aureus in Korea. J Clin Microbiol. 2000;38:3879–3881. - PMC - PubMed

MeSH terms

LinkOut - more resources